Literature DB >> 32501207

Regional Differences in the Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017.

Holly Hedegaard, Brigham A Bastian, James P Trinidad, Merianna R Spencer, Margaret Warner.   

Abstract

Objective-This report describes regional differences in the specific drugs most frequently involved in drug overdose deaths in the United States in 2017. Methods-Data from the 2017 National Vital Statistics System-Mortality files were linked to electronic files containing literal text information from death certificates. Drug overdose deaths were identified using International Classification of Diseases, 10th Revision underlying cause-of-death codes X40-X44, X60-X64, X85, and Y10-Y14. Drug mentions were identified using established methods for searching the literal text from death certificates. Deaths were assigned to 1 of 10 U.S. Department of Health and Human Services (HHS) regions based on the decedent's state of residence. The number and age-adjusted death rate was determined for the 10 drugs most frequently involved in drug overdose deaths in 2017, both nationally and for each HHS region. Deaths involving more than one drug were counted in all relevant drug categories (i.e., the same death could be counted in more than one drug category). Results-Among drug overdose deaths in 2017 that mentioned at least 1 specific drug on the death certificate, the 10 drugs most frequently involved included fentanyl, heroin, cocaine, methamphetamine, alprazolam, oxycodone, morphine, methadone, hydrocodone, and diphenhydramine. Regionally, 6 drugs (alprazolam, cocaine, fentanyl, heroin, methadone, and oxycodone) were found among the 10 most frequently involved drugs in all 10 HHS regions, although the relative ranking varied by region. Age-adjusted rates of drug overdose deaths involving fentanyl or deaths involving cocaine were higher in the regions east of the Mississippi River, while age-adjusted rates for drug overdose deaths involving methamphetamine were higher in the West. The regional patterns observed did not change after adjustment for differences in the specificity of drug reporting. Conclusions-The drugs most frequently involved in drug overdose deaths in 2017 varied by HHS region. Understanding the regional differences can help inform local prevention and policy efforts. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 32501207

Source DB:  PubMed          Journal:  Natl Vital Stat Rep        ISSN: 1551-8922


  28 in total

1.  Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018.

Authors:  Mary C Figgatt; Anna E Austin; Mary E Cox; Scott Proescholdbell; Stephen W Marshall; Rebecca B Naumann
Journal:  Drug Alcohol Depend       Date:  2021-01-02       Impact factor: 4.492

2.  Trends in Methamphetamine Use Among Men Who Have Sex with Men in New York City, 2004-2017.

Authors:  Alexis V Rivera; Graham Harriman; Sidney A Carrillo; Sarah L Braunstein
Journal:  AIDS Behav       Date:  2020-11-13

3.  Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments.

Authors:  Alana M Vivolo-Kantor; Brooke E Hoots; Puja Seth; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2020-09-25       Impact factor: 4.492

4.  Bupropion and Naltrexone in Methamphetamine Use Disorder.

Authors:  Madhukar H Trivedi; Robrina Walker; Walter Ling; Adriane Dela Cruz; Gaurav Sharma; Thomas Carmody; Udi E Ghitza; Aimee Wahle; Mora Kim; Kathy Shores-Wilson; Steven Sparenborg; Phillip Coffin; Joy Schmitz; Katharina Wiest; Gavin Bart; Susan C Sonne; Sidarth Wakhlu; A John Rush; Edward V Nunes; Steven Shoptaw
Journal:  N Engl J Med       Date:  2021-01-14       Impact factor: 91.245

5.  Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time.

Authors:  Keri N Althoff; Kathryn M Leifheit; Ju Nyeong Park; Aruna Chandran; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-09-25       Impact factor: 4.492

6.  Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys.

Authors:  David R Maguire; Lisa R Gerak; Jesus J Sanchez; Martin A Javors; Alex Disney; Stephen M Husbands; Charles P France
Journal:  Neuropsychopharmacology       Date:  2020-05-06       Impact factor: 7.853

7.  Incorporating space and time into random forest models for analyzing geospatial patterns of drug-related crime incidents in a major U.S. metropolitan area.

Authors:  Zhiyue Xia; Kathleen Stewart; Junchuan Fan
Journal:  Comput Environ Urban Syst       Date:  2021-01-29

8.  Circumstances of overdose among suburban women who use opioids: Extending an urban analysis informed by drug, set, and setting.

Authors:  Aukje K Lamonica; Miriam Boeri; Jeffrey Turner
Journal:  Int J Drug Policy       Date:  2020-12-26

9.  Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease.

Authors:  Ryan R Cook; Randy Torralva; Caroline King; Paula J Lum; Hansel Tookes; Canyon Foot; Pamela Vergara-Rodriguez; Allan Rodriguez; Laura Fanucchi; Gregory M Lucas; Elizabeth N Waddell; P Todd Korthuis
Journal:  Drug Alcohol Depend       Date:  2021-09-20       Impact factor: 4.492

10.  Evaluation of Policy Effectiveness by Mathematical Modeling for the Opioid Crisis with Spatial Study and Trend Analysis.

Authors:  Jiaji Pan; Shen Ren; Xiuxiang Huang; Ke Peng; Zhongxiang Chen
Journal:  Healthcare (Basel)       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.